Skip to main content

Table 1 Demographic, immunological, virological, and therapeutic characteristics

From: HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon

Variables

N = 84

%

Gender

  

Female

39

46.4

Male

45

53.6

Age range

  

[0–15 years]

2

2.4

[15–30 years]

10

11.9

[30–45 years]

30

35.7

[45–60 years]

36

42.8

[60 to more]

6

7.1

TCD4 lymphocytes

  

CD4 < 200 mm3

75

89.3

200 < CD4 < 500 mm3

6

7.1

CD4 ≥ 500 mm3

3

3.6

Viral loads

 

VL > 1000

82

97.6

Undetectable

2

2.4

ART duration

 

less than five years

0

0

[5–10 years]

13

15.5

[10–15 years]

30

35.7

[15–20 years]

36

42.9

[20 years or more]

5

5.9

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us